Diagnosis and management of resistant hypertension: state of the art.

Resistant hypertension is defined as a lack of ambulatory blood pressure response to optimized medical treatment after exclusion of secondary hypertension in patients who are fully adherent to antihypertensive therapy. Patients with resistant hypertension are at high risk of complications, particula...

Descripción completa

Detalles Bibliográficos
Publicado en:Nature Reviews Nephrology Vol. 14; no. 7; pp. 428 - 442
Autores principales: Wei, Fang-Fei, Zhang, Zhen-Yu, Huang, Qi-Fang, Staessen, Jan A.
Formato: research Journal Article
Publicado: Springer Nature Jul2018
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=131021985&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 131021985
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        17595061
        8UU5
      jtl: Nature Reviews Nephrology
      issn: 17595061
      maglogo: N
    pubinfo:
      dt: Jul2018
      vid: 14
      iid: 7
      pid: 2579
      pub: Springer Nature
      place: Dordrecht, <Blank>
    artinfo:
      ui:
        131021985
        131021985
        NLM29700488
        131021985
        10.1038/s41581-018-0006-6
        NLM29700488
        131021985
      ppf: 428
      ppct: 14
      formats:
      tig:
        atl: Diagnosis and management of resistant hypertension: state of the art.
      aug:
        au:
          Wei, Fang-Fei
          Zhang, Zhen-Yu
          Huang, Qi-Fang
          Staessen, Jan A.
        affil: Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium
      sug:
        subj:
          Electrotherapy Methods
          Hypertension Diagnosis
          Coronary Vasospasm Therapy
          Antihypertensive Agents Therapeutic Use
          Hypertension Therapy
          Sympathectomy
          Pressoreceptors
          Coronary Vasospasm Diagnosis
          Renal Artery Innervation
          Heterocyclic Compounds Therapeutic Use
          Renal Artery Surgery
          Blood Pressure Determination
          Hypertension Epidemiology
          Arteriovenous Shunt, Surgical
          Spironolactone Therapeutic Use
          Aldosterone Antagonists Therapeutic Use
          Animal Studies
          Coronary Vasospasm Epidemiology
          Carotid Arteries
          Baroreflex Physiology
          Human
          Medication Compliance
          Carotid Body Surgery
          Sodium Channel Blockers Therapeutic Use
          Scales
      ab: Resistant hypertension is defined as a lack of ambulatory blood pressure response to optimized medical treatment after exclusion of secondary hypertension in patients who are fully adherent to antihypertensive therapy. Patients with resistant hypertension are at high risk of complications, particularly cardiovascular events, and optimization of medical treatment remains the cornerstone of their management. Such optimization should be based on simple algorithms and include the use of aldosterone antagonists. The available data from clinical trials do not support the use of device-based approaches such as renal denervation, baroreflex activation therapy or arteriovenous anastomosis for the treatment of resistant hypertension in the majority of patients. Therefore, device treatment remains a last-resort for patients with truly resistant hypertension in the context of clinical research in highly skilled tertiary referral centres. Future research should focus on improving understanding of the intrinsic (physiological and psychological factors) and extrinsic (environmental stressors) mechanisms that contribute to a lack of response to blood-pressure-lowering drugs in adherent patients. The use of biomarkers to identify patients with early target organ damage and new technologies, such as renal nerve stimulation, to predict blood pressure responses to renal denervation could aid the selection of patients who might benefit from device therapies.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N